Health Care SPDR (ETF)

  • Highlights from the Goldman Sachs Healthcare Conference

    By John Macris - June 18, 2013 | Tickers: AET, BMRN, XLV

    Goldman Sachs recently hosted its 34th Annual Global Healthcare Conference on June 11 – 13 in Rancho Palos Verdes, CA.

    Healthcare was considered a defensive sector during the 2008–09 recession, but I believe it will continue to perform going forward. An aging baby boomer population, the Obamacare rollout, and a growing need for disease treatments should lead to profitable investing for many years to come.

    The Health Care Select Sector more »

  • Is CVS Caremark Still a Buy?

    By Shmulik Karpf - May 8, 2013 | Tickers: CVS, XLV, WMT, WAG

    Shares of CVS Caremark (NYSE: CVS) have enjoyed a fantastic run over the past six months. From a price of $44 only six months ago, shares advanced to a roughly $60 price tag today - an impressive 36% rise in such a short time. Not only that, but CVS also vastly outperformed the health care sector as a whole. Take a look at the graph below.

    <img alt="" src="" />

    From looking at the graph more »

  • Three Stocks for a Tired Rally

    By Declan Fallon - April 4, 2013 | Tickers: GWRE, XLV, BLOX, PDCE

    The rally started in 2009 has now passed its fourth birthday and is starting to look like its age. In the past couple of weeks we have seen defensive sectors like Health Care (NYSEMKT: XLV), Staples and Utilities take the lead, their respective ETFs adding nearly 3%. While at the same time money rotated out of cyclical sectors like Industrials, Financials and Materials. Materials are down nearly 4% for the more »

  • Why Cyprus Could Spell the End of the EU

    By Bob Chandler - April 3, 2013 | Tickers: XLV, EUO, EPV, XLU

    The European Union (EU) looked like it dodged another crisis when Cyprus agreed to a 10 billion euro bailout in return for some radical reforms. Unfortunately, the way it was handled increases the risk of a messy dissolution of the EU, and such a break up could devastate any unprepared investment portfolio on a scale similar to that of the 2008-2009 financial meltdown.

    Here’s why the Cyprus deal puts more »

  • High Risk, High Reward: Jon Najarian's Top 3 ETF Plays for 2013

    By John Macris - February 13, 2013 | Tickers: DRN, XLV, AMJ

    The world’s largest ETF conference is being held this week here in warm and sunny South Florida, attracting some of Wall Street’s best minds away from New York during the frigid winter months., self-labeled as the leading independent authority on ETFs, indexes, and index funds, is hosting its annual “Inside ETFs” Conference from February 10 - 12 at the Westin Diplomat in Hollywood, Florida.

    My former mentor more »

  • Is My Nose Bleeding? I Just Got "Einhorned"

    By Kyle Metivier - February 7, 2013 | Tickers: CI, XLV, VTR

    “I could tell that my parents hated me. My bath toys were a toaster and a radio.” – Rodney Dangerfield

    My name will never be used as a verb. First off, it’s much too difficult for most people to even attempt to pronounce. Looking at it, do you Americanize it? Do you go old school French-Canadian? What’s the proper tense? I’m at peace with it. Believe me, it more »

  • Stock Picking with Einhorn

    By Kyle Metivier - October 9, 2012 | Tickers: CMG, CI, XLV, VTR, YUM

    When an All-Star fund manager targets one of your stocks as a potential opportunity for a short, what do you do? When the discussion includes jokes people actually laugh at, and a Spielberg-inspired Power Point presentation, what should our initial reaction be? Should we even have one at all? Do we treat these people like E.F. Hutton and throw the investment off a bridge the first chance we get more »

  • Here's to Your Investing Health

    By Kyle Metivier - September 30, 2012 | Tickers: CI, XLV, VTR, WLP

    “The first wealth is health.” – Ralph Waldo Emerson

    I haven’t written much (translation: anything), about healthcare stocks due in large part to the Obamacare/Nobamacare/election, fracas that is swimming around every one of us like starving sharks at feeding time. Following the Supreme Court’s ruling concerning the Patient Protection and Affordable Care Act (PPACA, more commonly referred to as Obamacare), I think it’s time I started more »

  • Three Healthcare ETFs That May be Poised to Rebound

    By Jeff Stouffer - September 5, 2012 | Tickers: FTCS, XLV, IYH, JNJ, REGN

    Political events have always had an effect on the state of the healthcare industry. Now that a lot of the unknowns from a few years ago have come and gone, it appears that structural adjustments to the industry have commenced and a return to positive momentum is in place.


    Exchange-traded funds that are based on indexes in this sector offer a cost effective, tax efficient, and transparent portfolio that take more »

  • There is Value in Johnson & Johnson

    By Andrés Cardenal - May 15, 2012 | Tickers: XLV, JNJ, SPY

    Johnson & Johnson (NYSE: JNJ) has been a notable underperformer in the last two years, the chart from Yahoo! Finance compares the stock with two relevant ETFs: S&P Depository Receipts (NYSEMKT: SPY) which tracks the S&P 500 index, and Health Care SPDR (NYSEMKT: XLV) which invests in healthcare stocks. The company has produced almost no price gains and significantly lagged its benchmarks during the comparison period.

    <img src="/media/images/user_1532/jnj_comparison_large.png" />

    Although the company more »

  • Three healthcare ETFs for long term investors

    By Andrés Cardenal - March 7, 2012 | Tickers: XLV, IBB, IXJ

    The healthcare sector is facing some important headwinds: changing regulations and economic policies, patent expirations and high competitiveness in the industry can reduce visibility and generate some considerable doubts in investors’ minds. However, long term demand perspectives look very attractive for this sector, and valuations are quite reasonable as well.

    The world population is aging; demographic trends like the baby boomers reaching retirement age or the increase in life expectancy more »